Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_assertion type Assertion NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_head.
- NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_assertion description "[In this study, we evaluated if PITX2 DNA methylation is a marker for disease recurrence in lymph node-negative (LNN), steroid hormone receptor-positive (HR+) breast cancer patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_provenance.
- NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_assertion evidence source_evidence_literature NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_provenance.
- NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_assertion SIO_000772 17965955 NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_provenance.
- NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_assertion wasDerivedFrom befree-20150227 NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_provenance.
- NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_assertion wasGeneratedBy ECO_0000203 NP626488.RAchDD5S3qMtBpgSTyqHKErHvpczuFGz-iT0peWpBz9OY130_provenance.